首页GRAL • NASDAQ
add
Grail Inc
昨日收盘价
$94.93
当日价格范围
$91.15 - $95.33
年度波幅
$16.10 - $115.76
市值
37.06亿 USD
平均交易量
114.46万
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年9月info | 年同比变化 |
|---|---|---|
收入 | 3619.40万 | 26.32% |
经营支出 | 1.45亿 | -25.53% |
净收入 | -8897.70万 | 29.21% |
净利润率 | -245.83 | 43.96% |
每股收益 | -2.46 | 29.77% |
息税折旧摊销前利润 | -8630.90万 | 40.18% |
有效税率 | 25.05% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 5.40亿 | -36.72% |
总资产 | 26.01亿 | -16.58% |
负债总额 | 3.61亿 | -31.91% |
权益总额 | 22.40亿 | — |
发行在外的股份 | 3898.22万 | — |
市净率 | 1.53 | — |
资产回报率 | -11.81% | — |
资本回报率 | -13.40% | — |
现金流
现金净变动
| (USD) | 2025年9月info | 年同比变化 |
|---|---|---|
净收入 | -8897.70万 | 29.21% |
来自运营的现金 | -6324.50万 | 39.53% |
投资现金 | 6667.30万 | 6,966.43% |
融资现金 | — | — |
现金净变动 | 309.00万 | 102.93% |
自由现金流 | -1926.99万 | 60.50% |
简介
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
成立时间
2015
员工数量
1,000
